Breast cancer chemoresistance: emerging importance of cancer stem cells.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Surgical oncology

• Publication date

  2010-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.suronc.2009.01.004PMID 19251410
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy

  2008cited by this paper
• Quantitative Mass Spectrometry Identifies Drug Targets in Cancer Stem Cell‐Containing Side Population

  2008influential reference
• Alcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase (ALDH) activity in the sera of patients with liver cancer

  2008cited by this paper
• Stem-cell biology and cancer therapy: the more things change...

  2008cited by this paper
• Identification and expansion of human colon-cancer-initiating cells

  2007cited by this paper
• Long‐term clinical results of autologous infusion of mobilized adult bone marrow derived CD34+ cells in patients with chronic liver disease

  2007cited by this paper
• Comparative gene expression analysis of a chronic myelogenous leukemia cell line resistant to cyclophosphamide using oligonucleotide arrays and response to tyrosine kinase inhibitors.

  2007cited by this paper
• CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.

  2007cited by this paper
• Combination of SN-38 with gefitinib or imatinib overcomes SN-38-resistant small-cell lung cancer cells.

  2007cited by this paper
• Phenotypic characterization of human colorectal cancer stem cells

  2007cited by this paper
• Stem cells as a treatment for chronic liver disease and diabetes.

  2007cited by this paper
• CANCER STEM CELLS: A REVIEW

  2007cited by this paper
• Molecular definition of breast tumor heterogeneity.

  2007cited by this paper
• Stem cell ageing: does it happen and can we intervene?

  2007cited by this paper
• ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.

  2007cited by this paper
• The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation.

  2006cited by this paper
• Most Early Disseminated Cancer Cells Detected in Bone Marrow of Breast Cancer Patients Have a Putative Breast Cancer Stem Cell Phenotype

  2006cited by this paper
• CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis

  2006cited by this paper
• Characterization and Clinical Application of Human CD34+ Stem/Progenitor Cell Populations Mobilized into the Blood by Granulocyte Colony‐Stimulating Factor

  2006cited by this paper
• Our perception of developmental plasticity: esse est percipi (to be is to be perceived)?

  2006cited by this paper
• A Side Order of Stem Cells: The SP Phenotype

  2006cited by this paper
• Tumor stem cell niches: a new functional framework for the action of anticancer drugs.

  2006cited by this paper
• Tumour stem cell-targeted treatment: elimination or differentiation.

  2006cited by this paper
• Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

  2006cited by this paper
• Prevalence of CD44+/CD24-/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis.

  2005cited by this paper
• Tumour stem cells and drug resistance

  2005influential reference
• Stem cell biology and the cellular pathways of carcinogenesis

  2005cited by this paper
• Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer.

  2005cited by this paper
• Haematopoietic stem cells and repair of the ischaemic heart.

  2005cited by this paper
• Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties.

  2005cited by this paper
• Adult bone marrow-derived stem cells and the injured heart: just the beginning?

  2005cited by this paper
• Gefitinib reverses chemotherapy resistance in gefitinib-insensitive multidrug resistant cancer cells expressing ATP-binding cassette family protein.

  2005cited by this paper
• Putting the rap on Akt.

  2004cited by this paper
• Cancer stem cell biology: from leukemia to solid tumors.

  2004cited by this paper
• A distinct "side population" of cells with high drug efflux capacity in human tumor cells.

  2004cited by this paper
• Applying the principles of stem-cell biology to cancer

  2003cited by this paper
• Prospective identification of tumorigenic breast cancer cells

  2003cited by this paper
• Stem cells, cancer, and cancer stem cells

  2001cited by this paper
• Somatic support cells restrict germline stem cell self-renewal and promote differentiation

  2000cited by this paper
• [Annual meeting of the American Association for Cancer Research].

  2000cited by this paper
• CD44 cell adhesion molecules.

  1999cited by this paper
• Stem cells in breast epithelia

  1998cited by this paper
• Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

  1997cited by this paper
• Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo

  1996cited by this paper
• Primary bioassay of human myeloma stem cells.

  1977cited by this paper
• Quantitative studies of autotransplantation of human cancer. Preliminary report

  1961cited by this paper

• The Possibility of Plasma Membrane Transporters as Drug Targets in Oral Cancers

  2025cites this paper
• Cancer stem cells and tumor-associated macrophages as mates in tumor progression: mechanisms of crosstalk and advanced bioinformatic tools to dissect their phenotypes and interaction

  2025cites this paper
• Fusobacterium nucleatum-mimicking nanovehicles to overcome chemoresistance for breast cancer treatment by eliminating tumor-colonizing bacteria

  2024cites this paper
• The treatment landscape of triple-negative breast cancer

  2024cites this paper
• KYNU Expression Promotes Cisplatin Resistance in Esophageal Cancer

  2024cites this paper
• Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies

  2024cites this paper
• Emerging Intrinsic Therapeutic Targets for Metastatic Breast Cancer

  2023cites this paper
• Unraveling the Potential of miRNAs from CSCs as an Emerging Clinical Tool for Breast Cancer Diagnosis and Prognosis

  2023cites this paper
• Resistance to TOP-1 Inhibitors: Good Old Drugs Still Can Surprise Us

  2023cites this paper
• Nanotechnology Applications in Breast Cancer Immunotherapy.

  2023cites this paper
• TWIST1 activates cancer stem cell marker genes to promote epithelial-mesenchymal transition and tumorigenesis in esophageal squamous cell carcinoma

  2022cites this paper
• Breast cancer stem cell population in different molecular subtypes of breast cancer

  2022cites this paper
• Molecular Docking as a Therapeutic Approach for Targeting Cancer Stem Cell Metabolic Processes

  2022cites this paper
• Prognostic and Predictive Effects of Tumor and Plasma miR-200c-3p in Locally Advanced and Metastatic Breast Cancer

  2022cites this paper
• Kaempferol attenuates viability of ex-vivo cultured post-NACT breast tumor explants through downregulation of p53 induced stemness, inflammation and apoptosis evasion pathways.

  2022cites this paper
• Evaluation of CD44+/CD24- and Aldehyde Dehydrogenase Enzyme Markers in Cancer Stem Cells as Prognostic Indicators for Triple-Negative Breast Cancer

  2022cites this paper
• Countering Triple Negative Breast Cancer via Impeding Wnt/β-Catenin Signaling, a Phytotherapeutic Approach

  2022cites this paper
• Role of Cancer Stem-like Cells in the Process of Invasion and Mesenchymal Transformation by a Reconstituted Triple-negative Breast Cancer Cell Population Resistant to p53-induced Apoptosis

  2022cites this paper
• Therapies approach based on metabolism of cancer stem cells

  2021cites this paper
• ReviewCancer Stem Cells

  2021cites this paper
• miR-26b-5p suppresses chemoresistance in breast cancer by targeting serglycin

  2021cites this paper
• Fatty acid synthase as a feasible biomarker for triple negative breast cancer stem cell subpopulation cultured on electrospun scaffolds

  2021cites this paper
• Current treatment modalities in major gynecologic cancers: Emphasis on response rates

  2021cites this paper
• Eradication of Ovarian Cancer Stem Cells in Ovarian Cancer Using Stem Cell Therapy

  2021cites this paper
• Cancer Stem Cells—Key Players in Tumor Relapse

  2021cites this paper
• [Construction of an adriamycin-glycyrrhizin molecular complex and assessment of its antitumor activity].

  2021cites this paper
• Construction of Hierarchical-Targeting pH-Sensitive Liposomes to Reverse Chemotherapeutic Resistance of Cancer Stem-like Cells

  2021cites this paper
• An insight into the cancer stem cell survival pathways involved in chemoresistance in triple-negative breast cancer.

  2021cites this paper
• Inhibition of Notch1 reverses EMT and chemoresistance to cisplatin via direct downregulation of MCAM in triple‐negative breast cancer cells

  2020cites this paper
• Molecular Simulations Identify Target Receptor Kinases Bound by Astaxanthin to Induce Breast Cancer Cell Apoptosis

  2020cites this paper
• Cryoablation-activated enhanced nanodoxorubicin release for the therapy of chemoresistant mammary cancer stem-like cells.

  2020cites this paper
• Cancer Stem Cells: New Horizons in Cancer Therapies

  2020cites this paper
• MDR reversal for effective chemotherapy in breast cancer

  2020cites this paper
• Cancer stem cell secretome in the tumor microenvironment: a key point for an effective personalized cancer treatment

  2020cites this paper
• Cancer stem cells: A review from origin to therapeutic implications

  2020cites this paper
• Counteracting Chemoresistance with Metformin in Breast Cancers: Targeting Cancer Stem Cells

  2020cites this paper
• 3-Acetyl-11-keto-β-boswellic acid inhibits cancer cell invasion and induces apoptosis in breast cancer cells by abrogating the EGFR-mediated PI3K/Akt pathway

  2020cites this paper
• Cancer cells stemness: A doorstep to targeted therapy.

  2020cites this paper
• Controversies in Isolation and Characterization of Cancer Stem Cells

  2020cites this paper
• [A Modified Lentivirus-Based Reporter for Magnetic Separation of Cancer Stem Cells].

  2020cites this paper
• Breast cancer: Biology, biomarkers, and treatments.

  2020cites this paper
• Potency of Combination of Fucoidan Microsphere and MiRNA-200b as Therapy in Chemoresistant Breast Cancer

  2020cites this paper
• THE ROLE OF MICRORNA-200C IN CHEMORESISTANT BREAST CANCER

  2020influential citation
• A Modified Lentivirus-Based Reporter for Magnetic Separation of Cancer Stem Cells

  2020cites this paper
• Targeting stem cells in the realm of drug-resistant breast cancer

  2019cites this paper
• Pharmacological targeting of mitochondria in cancer stem cells: An ancient organelle at the crossroad of novel anti‐cancer therapies

  2019cites this paper
• ABCG1 and Pgp identify drug resistant, self-renewing osteosarcoma cells.

  2019cites this paper
• Ovarian cancer stem cells and targeted therapy

  2019cites this paper
• Characteristics of Cancer Stem Cells and Immune Checkpoint Inhibition

  2019cites this paper
• Triple-Negative Breast Cancer: Current Understanding and Future Therapeutic Breakthrough Targeting Cancer Stemness

  2019cites this paper
• Mitochondrial determinants of chemoresistance

  2019cites this paper
• Whole Grain Consumption for the Prevention and Treatment of Breast Cancer

  2019cites this paper
• Therapies to Overcome Multidrug-Resistant Receptors

  2019cites this paper
• Current Applications for Overcoming Resistance to Targeted Therapies

  2019influential citation
• Overexpression of CD 133 confers poor prognosis in colorectal cancer : a systematic review and meta-analysis

  2019cites this paper
• MiR-130a-3p inhibits migration and invasion by regulating RAB5B in human breast cancer stem cell-like cells.

  2018cites this paper
• ANTICANCER EFFECT OF AFRICAN LEAVES (VERNONIA AMYGDALINA DEL.) TO T47D CELL RESISTANT

  2018cites this paper
• Stem-like Human Breast Cancer Cells Initiate Vasculogenic Mimicry on Matrigel

  2018cites this paper
• Moving Breast Cancer Therapy up a Notch

  2018cites this paper
• Optimized Dosing Schedule Based on Circadian Dynamics of Mouse Breast Cancer Stem Cells Improves the Antitumor Effects of Aldehyde Dehydrogenase Inhibitor.

  2018influential citation
• Therapeutic potency of oncolytic virotherapy–induced cancer stem cells targeting in brain tumors, current status, and perspectives

  2018cites this paper
• Cancer stem cell markers ALDH1 and CD44+/CD24– phenotype and their prognosis impact in invasive ductal carcinoma

  2018cites this paper
• Diagnostic value of MRI-based 3D texture analysis for tissue characterisation and discrimination of low-grade chondrosarcoma from enchondroma: a pilot study

  2018cites this paper
• Astragaloside IV enhances taxol chemosensitivity of breast cancer via caveolin‐1‐targeting oxidant damage

  2018cites this paper
• Regulation of breast cancer biomarkers by intrinsic and extrinsic factors

  2018cites this paper
• Prediction of individual chemoprophylaxis for radiation carcinogenesis in experiment

  2017cites this paper
• GATA3 and TRPS1 are distinct biomarkers and prognostic factors in breast cancer: database mining for GATA family members in malignancies

  2017cites this paper
• Direct inhibition of ACTN4 by ellagic acid limits breast cancer metastasis via regulation of β-catenin stabilization in cancer stem cells

  2017cites this paper
• Hsp90α Mediates BMI1 Expression in Breast Cancer Stem/Progenitor Cells through Facilitating Nuclear Translocation of c-Myc and EZH2

  2017cites this paper
• MiR-519d impedes cisplatin-resistance in breast cancer stem cells by down-regulating the expression of MCL-1

  2017cites this paper
• ABC Transporters in Cancer Stem Cells: Beyond Chemoresistance

  2017cites this paper
• Multicellular tumor spheroids: a relevant 3D model for the in vitro preclinical investigation of polymer nanomedicines

  2017cites this paper
• Systems biology approach in understanding metabolic reprogramming in breast cancer

  2017cites this paper
• Drug Resistance Driven by Cancer Stem Cells and Their Niche

  2017cites this paper
• Overexpression of miR-489 enhances efficacy of 5-fluorouracil-based treatment in breast cancer stem cells by targeting XIAP

  2017cites this paper
• 18F-FDG PET/CT in lung cancer. The added value of quantification.

  2017cites this paper
• Immunohistochemical analyses of CD44 variant isoforms in invasive micropapillary carcinoma of the breast: comparison with a concurrent conventional invasive carcinoma of no special type component

  2016cites this paper
• Tumor microenvironment-mediated chemoresistance in breast cancer.

  2016cites this paper
• Potential biomarker panels in overall breast cancer management: advancements by multilevel diagnostics.

  2016cites this paper
• Clinicopathological and prognostic significance of cd 133 in esophageal cancer : a meta-analysis

  2016cites this paper
• A literature mining-based approach for identification of cellular pathways associated with chemoresistance in cancer

  2016cites this paper
• Consecutive salinomycin treatment reduces doxorubicin resistance of breast tumor cells by diminishing drug efflux pump expression and activity.

  2016cites this paper
• Combined cancer therapy with hyaluronan-decorated fullerene-silica multifunctional nanoparticles to target cancer stem-like cells.

  2016cites this paper
• Chemoresistance in breast cancer stem cells

  2016cites this paper
• CD 133 expression may be useful as a prognostic indicator in glioblastoma multiforme : a meta-analysis

  2016cites this paper
• Microenvironment-Responsive Three-Pronged Approach Breaking Traditional Chemotherapy to Target Cancer Stem Cells for Synergistic Inoperable Large Tumor Therapy.

  2016cites this paper
• Estudi de l'efecte de la curcumina en la reversió de la resistència adquirida a oxaliplatí mitjançant la inhibició de la via de senyalització de NF-kB en models cel·lulars de càncer colorectal

  2016cites this paper
• Comments on the "Prognostic Impact and Clinicopathological Correlation of CD133 and ALDH1 Expression in Invasive Breast Cancer"

  2016cites this paper
• Tumor-Initiating Cells: Emerging Biophysical Methods of Isolation

  2016cites this paper
• WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells.

  2016cites this paper
• Breast cancer stem-like cells: clinical implications and therapeutic strategies

  2016cites this paper
• Crosstalk between TGF-β signaling and miRNAs in breast cancer metastasis

  2016cites this paper
• Abnormal expression of the Notch and Wnt/β-catenin signaling pathways in stem-like ALDHhiCD44+ cells correlates highly with Ki-67 expression in breast cancer

  2015cites this paper
• Let-7a regulates mammosphere formation capacity through Ras/NF-κB and Ras/MAPK/ERK pathway in breast cancer stem cells

  2015cites this paper
• Regulation of stem cells-related signaling pathways in response to doxorubicin treatment in Hs578T triple-negative breast cancer cells

  2015cites this paper
• Expression of miR-200c in claudin-low breast cancer alters stem cell functionality, enhances chemosensitivity and reduces metastatic potential

  2015influential citation
• MicroRNA-34a suppresses the breast cancer stem cell-like characteristics by downregulating Notch1 pathway

  2015cites this paper
• Prognostic Impact and Clinicopathological Correlation of CD133 and ALDH1 Expression in Invasive Breast Cancer

  2015cites this paper
• Epithelial-Mesenchymal Transition Phenotype Is Associated with Clinicopathological Factors That Indicate Aggressive Biological Behavior and Poor Clinical Outcomes in Invasive Breast Cancer

  2015cites this paper
• The Role of MicroRNAs in the Chemoresistance of Breast Cancer

  2015influential citation